Review: Hydroxyoctadecadienoic acids: novel regulators of macrophage differentiation and atherogenesis
Hydroxyoctadecadienoic acids (HODEs) are stable oxidation products of linoleic acid, the generation of which is increased where oxidative stress is increased, such as in diabetes. In early atherosclerosis, 13-HODE is generated in macrophages by 15-lipoxygenase-1. This enhances protective mechanisms...
Main Authors: | Venkat Vangaveti, Bernhard T. Baune, R. Lee Kennedy |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2010-06-01
|
Series: | Therapeutic Advances in Endocrinology and Metabolism |
Online Access: | https://doi.org/10.1177/2042018810375656 |
Similar Items
-
Thematic review series: The Immune System and Atherogenesis. Cytokine regulation of macrophage functions in atherogenesis
by: Alan Daugherty, et al.
Published: (2005-09-01) -
The macrophage in atherogenesis
by: Davis, John Beresford
Published: (1987) -
9- and 13-HODE regulate fatty acid binding protein-4 in human macrophages, but does not involve HODE/GPR132 axis in PPAR-γ regulation of FABP4
by: Venkat Vangaveti, et al.
Published: (2018-05-01) -
Review: Free fatty acid receptors: emerging targets for treatment of diabetes and its complications
by: R. Lee Kennedy, et al.
Published: (2010-10-01) -
13-(S)-Hydroxyoctadecadienoic acid (13-HODE) incorporation and conversion to novel products by endothelial cells1
by: Xiang Fang, et al.
Published: (1999-04-01)